Thomas Roos - UnitedHealth Group Senior Vice President, Chief Accounting Officer
| UNH Stock | USD 445.63 6.43 1.46% |
President
Mr. Thomas E. Roos is Senior Vice President, Chief Accounting Officer of the Company. Mr. Roos is Senior Vice President and Chief Accounting Officer of UnitedHealth Group and has served in that capacity since August 2015. Prior to joining UnitedHealth Group, Mr. Roos was a Partner at Deloitte Touche LLP, an independent registered accounting firm, from September 2007 to August 2015. since 2015.
| Age | 51 |
| Tenure | 9 years |
| Address | UnitedHealth Group Center, Minnetonka, MN, United States, 55343 |
| Phone | 952 936 1300 |
| Web | https://www.unitedhealthgroup.com |
UnitedHealth Group Management Efficiency
The company has Return on Asset of 0.0779 % which means that on every $100 spent on assets, it made $0.0779 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2499 %, implying that it generated $0.2499 on every 100 dollars invested. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities. The UnitedHealth Group's current Return On Equity is estimated to increase to 0.26, while Return On Tangible Assets are projected to decrease to 0.09. As of now, UnitedHealth Group's Total Current Assets are increasing as compared to previous years. The UnitedHealth Group's current Intangible Assets is estimated to increase to about 16 B, while Non Currrent Assets Other are projected to decrease to under 10.9 B.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Beth Chesmha | Elevance Health | 55 | |
| Heidi Margulis | Humana Inc | 63 | |
| Kenneth Fasola | Centene Corp | 64 | |
| Christopher Kay | Humana Inc | 50 | |
| Ken Yamaguchi | Centene Corp | N/A | |
| CHRISTOPHER HOCEVAR | Cigna Corp | 43 | |
| Brandy Burkhalter | Centene Corp | 48 | |
| Julie Trudell | Molina Healthcare | N/A | |
| Mark Keim | Molina Healthcare | 59 | |
| Everett Neville | Cigna Corp | 59 | |
| Charlotte LeBlanc | Alignment Healthcare LLC | N/A | |
| Bethanie Stein | Humana Inc | N/A | |
| Troyen Brennan | CVS Health Corp | 66 | |
| Shawn Guertin | CVS Health Corp | 60 | |
| Lisa Bisaccia | CVS Health Corp | 62 | |
| Kristen Lauria | Cigna Corp | 51 | |
| Christopher Isaak | Centene Corp | 53 | |
| Shannon Bagley | Centene Corp | 45 | |
| Jonathan Roberts | CVS Health Corp | 65 | |
| Christopher MBA | Cigna Corp | N/A | |
| Joshua Flum | CVS Health Corp | 50 | |
Management Performance
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.0779 |
UnitedHealth Group Leadership Team
Elected by the shareholders, the UnitedHealth Group's board of directors comprises two types of representatives: UnitedHealth Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UnitedHealth. The board's role is to monitor UnitedHealth Group's management team and ensure that shareholders' interests are well served. UnitedHealth Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UnitedHealth Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gail Wilensky, Independent Director | ||
| Timothy, Independent Director | ||
| Richard Burke, Independent Chairman of the Board | ||
| Valerie Rice, Independent Director | ||
| Andrew Witty, Group President, Chief Executive Officer, Executive Vice President, Director | ||
| Terry Clark, Executive Officer | ||
| Sir Witty, CEO Director | ||
| Stephen Hemsley, Non-Executive Chairman of the Board | ||
| John Rex, Chief Financial Officer, Executive Vice President | ||
| Dirk McMahon, President and Chief Operating Officer; Chief Executive Officer of UnitedHealthcare | ||
| DEllen Wilson, Executive Vice President - Human Capital | ||
| Steven Nelson, Executive Vice President CEO of UnitedHealthcare | ||
| Zachary Sopcak, Senior Relations | ||
| William McNabb, Independent Director | ||
| John Noseworthy, Independent Director | ||
| Larry Renfro, Vice Chairman and CEO of Optum | ||
| Robert Darretta, Independent Director | ||
| Jennifer Smoter, Senior Officer | ||
| William Ballard, Independent Director | ||
| Glenn Renwick, Independent Director | ||
| Rupert Bondy, Ex Officer | ||
| Sandeep Dadlani, Executive Officer | ||
| Michele Hooper, Lead Independent Director | ||
| Timothy Flynn, Independent Director | ||
| Thomas Roos, Senior Vice President, Chief Accounting Officer | ||
| Rodger Lawson, Independent Director | ||
| Frances Jacobs, IR Contact Officer | ||
| Matthew Friedrich, Executive Vice President Chief Legal Officer | ||
| Kenneth Shine, Independent Director | ||
| Edson Bueno, Director | ||
| D Wilson, Executive Vice President - Human Capital | ||
| F McNabb, Independent Director | ||
| Paul Garcia, Independent Director | ||
| Marianne Short, Executive Vice President, Chief Legal Officer | ||
| David Wichmann, Chief Executive Officer, Director | ||
| Patricia Lewis, Chief Human Resource Officer, Executive Vice President | ||
| Brian Thompson, Executive UnitedHealthcare | ||
| James Barry, Director Pennsylvania |
UnitedHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UnitedHealth Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.0779 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 458.81 B | ||||
| Shares Outstanding | 921.93 M | ||||
| Shares Owned By Insiders | 0.20 % | ||||
| Shares Owned By Institutions | 90.30 % | ||||
| Number Of Shares Shorted | 7.77 M | ||||
| Price To Earning | 26.34 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for UnitedHealth Stock analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is UnitedHealth Group's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.16 | Dividend Share 7.29 | Earnings Share 23.84 | Revenue Per Share 400.455 | Quarterly Revenue Growth 0.141 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.